Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Commissione europea
CORDIS
Progetti e risultati
Response of freshly isolated follicular lymphoma cells to rituximab

Response of freshly isolated follicular lymphoma cells to rituximab

Dettagli del progetto

Costo totale:

EUR 65 756

Contributo UE:

EUR 65 756

Coordinato in:

Italy

Argomento (i):

1.1.1.-2. - Key action Control of Infectious Diseases

Meccanismo di finanziamento:

RGI - Research grants (individual fellowships)

Obiettivo

Analysis of gene patterns induced by rituximab in freshly isolated follicular lymphoma cells and of their in-vitro susceptibility to rituximab combined with fludarabine and cyclophophamide

Coordinatore

MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH

Italy

Via Eritrea 62
20157 MILANO
Italy
See on map

Contatto amministrativo: Silvio GARATTINI

Argomenti

Life Sciences - Medicine and Health - Safety - Scientific Research - Social sciences and humanities

Download [Stampa PDF] [Stampa RTF] [Stampa XML]

Booklet

My booklet (0)